Chevy Chase Trust Holdings LLC Has $20.44 Million Stock Position in Agilent Technologies, Inc. (NYSE:A)

Chevy Chase Trust Holdings LLC lowered its stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 3.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 152,137 shares of the medical research company's stock after selling 5,663 shares during the quarter. Chevy Chase Trust Holdings LLC owned approximately 0.05% of Agilent Technologies worth $20,438,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Van ECK Associates Corp boosted its stake in shares of Agilent Technologies by 6.6% in the 3rd quarter. Van ECK Associates Corp now owns 2,976,905 shares of the medical research company's stock valued at $442,011,000 after purchasing an additional 183,716 shares during the last quarter. Vestal Point Capital LP bought a new position in shares of Agilent Technologies in the 3rd quarter valued at about $14,848,000. Empowered Funds LLC boosted its stake in shares of Agilent Technologies by 29.8% in the 3rd quarter. Empowered Funds LLC now owns 30,978 shares of the medical research company's stock valued at $4,592,000 after purchasing an additional 7,111 shares during the last quarter. S.E.E.D. Planning Group LLC boosted its stake in shares of Agilent Technologies by 12.7% in the 4th quarter. S.E.E.D. Planning Group LLC now owns 42,587 shares of the medical research company's stock valued at $5,721,000 after purchasing an additional 4,805 shares during the last quarter. Finally, National Pension Service raised its position in shares of Agilent Technologies by 10.8% in the 3rd quarter. National Pension Service now owns 702,631 shares of the medical research company's stock valued at $104,327,000 after acquiring an additional 68,670 shares during the period.

Agilent Technologies Stock Up 1.5 %

Shares of A traded up $2.01 during mid-day trading on Wednesday, hitting $137.21. 1,666,743 shares of the company's stock were exchanged, compared to its average volume of 1,679,436. Agilent Technologies, Inc. has a 52 week low of $124.16 and a 52 week high of $155.35. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58. The company has a 50-day simple moving average of $141.21 and a 200 day simple moving average of $139.31. The company has a market cap of $39.15 billion, a PE ratio of 31.04, a P/E/G ratio of 3.65 and a beta of 1.07.

Agilent Technologies (NYSE:A - Get Free Report) last released its earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.05. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The business had revenue of $1.70 billion during the quarter, compared to analysts' expectations of $1.67 billion. During the same period last year, the business earned $1.38 earnings per share. The firm's revenue was up .8% on a year-over-year basis. On average, research analysts forecast that Agilent Technologies, Inc. will post 5.56 earnings per share for the current fiscal year.

Insider Activity at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the transaction, the chief executive officer now directly owns 39,652 shares of the company's stock, valued at $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Analysts Set New Price Targets

A number of analysts recently weighed in on A shares. Bank of America cut their price target on shares of Agilent Technologies from $153.00 to $150.00 and set a "neutral" rating on the stock in a research report on Friday, December 13th. Sanford C. Bernstein cut their price target on shares of Agilent Technologies from $140.00 to $135.00 and set a "market perform" rating on the stock in a research report on Tuesday, November 26th. StockNews.com upgraded shares of Agilent Technologies from a "hold" rating to a "buy" rating in a report on Tuesday, December 24th. Barclays upgraded shares of Agilent Technologies from an "underweight" rating to an "equal weight" rating and raised their target price for the stock from $135.00 to $145.00 in a report on Monday, February 10th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating on the stock in a report on Tuesday, November 26th. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat, Agilent Technologies currently has a consensus rating of "Moderate Buy" and a consensus price target of $144.38.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.